drugset / Trial / NCT00649857

Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mg

NCT00649857

Phase 1 Completed 18 enrolled Mylan Pharmaceuticals Inc
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study was to investigate the bioequivalence of Mylan's cetirizine HCl tablets to Pfizer's Zyrtec® tablets following a single, oral 10 mg (1 x 10 mg) dose administered under fed conditions.

Timeline

Start
2002-11
Primary completion
2002-12
Completion
2002-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetirizine Other / unclassified 10 mg Oral

Indications

No indication recorded.